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Prolonged depolarization of skeletal muscle cells induces entry of extracellular calcium into muscle cells, an
event referred to as excitation-coupled calcium entry. Skeletal muscle excitation-coupled calcium entry relies
on the interaction between the 1,4-dihydropyridine receptor on the sarcolemma and the ryanodine receptor
on the sarcoplasmic reticulum membrane. In this study, we directly measured excitation-coupled calcium
entry by total internal reflection fluorescence microscopy in human skeletal muscle myotubes harbouring
mutations in the RYR1 gene linked to malignant hyperthermia (MH) and central core disease (CCD). We
found that excitation-coupled calcium entry is strongly enhanced in cells from patients with CCD compared
with individuals with MH and controls. Furthermore, excitation-coupled calcium entry induces generation of
reactive nitrogen species and enhances nuclear localization of NFATc1, which in turn may be responsible for
the increased IL-6 released by myotubes from patients with CCD.
INTRODUCTION
Excitation–contraction coupling (E–C coupling) is the
process whereby an electrical signal generated at the nerve
terminal is converted into a chemical signal, i.e. release of
Ca2+ from the sarcoplasmic reticulum (SR), leading to
muscle contraction and force development (1–3). Although
many proteins are involved in skeletal muscle E–C coupling,
the two key players are Ca2+ channels: the voltage-sensing
dihydropyridine receptor (DHPR), an L-type Ca2+ channel
∗To whom correspondence should be addressed. Tel: +41 61 265 2373; Fax: +41 61 265 3702; Email: susan.treves@unibas.ch (S.T.); Email: zor@
unife.it (F.Z.).
# The Author 2010. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Molecular Genetics, 2011, Vol. 20, No. 3 589–600
doi:10.1093/hmg/ddq506
Advance Access published on November 18, 2010
(Cav1.1) present on the transverse tubules, and the ryanodine
receptor (RyR1), an intracellular Ca2+ release channel loca-
lized on the SR terminal cisternae (2,4,5). Dysregulation of
calcium signals due to defects in RyR1 and Cav1.1 is the
underlying feature of malignant hyperthermia (MH; MIM
145600), a pharmacogenetic potentially lethal reaction
during anaesthesia, as well as several congenital myopathies,
including central core disease (CCD) characterized by
muscle weakness, fibre type-1 predominance and cores
running the length of the muscle fibre (CCD; MIM 11700),
subgroups of multiminicore disease (MIM 255320), certain
forms of centronuclear myopathy (6) and congenital fibre-type
disproportion (7). A great deal of data indicate that heterozy-
gous RYR1 mutations associated with the CCD phenotype
result in leaky channels, leading to the depletion of Ca2+
from SR stores (8–11). The ‘leaky channel’ hypothesis has
been challenged by data obtained using myotubes from
RyR1 knock out animals reconstituted with recombinant
RyR1 cDNA carrying the C-terminal (domain 3) RYR1
mutations p.I4898T, p.G4890R, p.R4892W, p.G4898R,
p.A4905V (12–14). Results using this model system have
suggested the alternative ‘E–C uncoupling’ hypothesis (15).
The leaky channel hypothesis predicts a decrease of the SR
Ca2+ load, whereas the E–C uncoupling hypothesis predicts
that the muscle weakness does not result from major
changes in the SR Ca2+ levels, but rather is due to a defect
in the molecular mechanism underlying the transmission of
the signal from sarcolemmal depolarization to the RyR1
(reviewed in 16). The alteration of SR calcium load deter-
mined by calcium leak is associated to an increase of the
resting calcium concentration in myotubes from CCD patients
(8,13), and this represents a second major difference between
the leaky and E–C uncoupling hypothesis. In resting con-
ditions, the level of intracellular [Ca2+] is ultimately deter-
mined by the influx of Ca2+ from the extracellular
environment which represents an ‘unlimited’ Ca2+ sink and
is much larger than the Ca2+ present within the SR stores
(17). If this were true, the leaky channel hypothesis would
also predict an increase of calcium influx in muscle cells
from CCD and MH susceptible (MHS) patients. Calcium
influx in muscle cells is operated by two main mechanisms:
excitation-coupled Ca2+ entry (ECCE) and store-operated
Ca2+ entry (SOCE). ECCE requires the functional interaction
between the DHPR and the RyR1 (18,19). Interestingly, dys-
pedic mouse myotubes over-expressing RyR1 cDNA harbour-
ing a mutation linked to MHS display enhanced ECCE
(20,21). However, experiments carried out in intact adult
and fetal mammalian skeletal muscle fibres have shown that
SOCE is mediated by Orai1 and Stim1 (22). It is plausible
that SOCE may be physiologically involved in refilling
depleted SR stores after intense muscle activity/or when the
store is leaky, as in the case of CCD-linked RYR1 mutations.
Alterations of Ca2+ entry and elevation of the resting [Ca2+]
may induce downstream events including (i) nuclear transloca-
tion of Ca2+-sensitive transcription factors involved in fibre-
type differentiation (23,24), and (ii) activation of
membrane-associated calcium-dependent enzymes such as
NO synthase (NOS) (25). Each of these events and/or the com-
bination of both may be responsible, at least in part, for some
of the phenotypes induced by RYR1 mutations. In this study,
we tested the hypothesis that human myotubes carrying
mutations linked to CCD and MHS display enhanced ECCE
and that the calcium influx via ECCE is associated with down-
stream events which may be implicated in the pathophysiology
of RYR1-related channelopathies. Our results show that cells
from MHS and CCD patients exhibit a significantly higher
ECCE compared with myotubes from control individuals.
Enhanced ECCE is linked to the activation of NOS and to
the nuclear translocation of nuclear factor of activated T
cells (NFAT), and may contribute to the increased release of
IL-6 from myotubes from CCD patients.
RESULTS
Ca21 homeostasis in muscle cells from control, MHS and
CCD patients
Figure 1 shows the resting [Ca2+] and peak Ca2+ increase
induced by 100 mM KCl in myotubes from control individuals
and cells from patients with MHS and CCD. The presence of
the RYR1 mutation p.V2168M in muscle cells from MHS indi-
viduals caused a small increase in the resting [Ca2+]. In our
hands, none of the other heterozygous MHS-linked mutations
significantly affected the resting [Ca2+], whereas it was
slightly but significantly elevated in all cells obtained from
patients with clinically and histopathologically confirmed
CCD (Fig. 1A). In addition, the peak Ca2+ in response to
stimulation with 100 mM KCl in the presence of 100 mM
La3+ was not different in myotubes from control and
MHS-RYR1-mutation-bearing individuals, whereas cells from
all patients with CCD showed a significant reduction in
Ca2+ release (Fig. 1B). These results on global Ca2+ homeo-
stasis are compatible with previous results by us and others on
the general characteristics of cells bearing RYR1 mutations
(8,13,26,27), and confirm that, irrespective of the underlying
mechanism, the peak Ca2+ response to KCl in myotubes
from MHS and control individuals is similar, whereas cells
from CCD individuals release less Ca2+ when depolarized.
Total internal reflection fluorescence microscopy in
fluo-4-loaded control human myotubes
The increased SR calcium leak via mutated RyR1 channels
has been proposed to be responsible for the transient
increase of the resting [Ca2+]. The steady increase of the
resting [Ca2+] is ultimately due to an increased Ca2+
influx from the extracellular environment into the myoplasm
(17). Thus, one would predict that the presence of leaky
RyR1 channels which are accompanied by increases in the
resting [Ca2+] should be linked to alterations of Ca2+
influx. We set out to test this hypothesis by investigating
influx by exploiting total internal reflection fluorescence
(TIRF) microscopy in combination with changes in the fluor-
escence of the fast Ca2+ indicator fluo-4. TIRF microscopy
is the best optical technology available to monitor
membrane- associated events at very high resolution (28).
Figure 2 shows the application of such a technique to
study Ca2+ influx in control human myotubes. Figure 2A
shows photomicrographs of myotubes by brightfield
microscopy (top left panel) and with a surface reflection
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interference contrast (SRIC) filter (top central panel) in order
to visualize the contact sites between the myotubes and the
glass coverslip (dark grey area). Cells were then excited at
488 nm using a Sapphire laser to monitor fluo-4 fluorescence
(top right panel), and the focal plane was fixed by means of
the Perfect Focus System (PFS) at the focal plane which had
been used to identify the ‘footprint’ of the cell on the glass
coverslip. The bottom panels of Figure 2A show time-lapse
changes (F/F0) in fluo-4 fluorescence during the application
of 100 mM KCl to cells which had been pre-treated with
500 mM ryanodine to block the release of Ca2+ from the
SR stores via RyRs (29,30). Prolonged KCl depolarization
results in a non-homogeneous increase of fluo-4 fluorescence
within the 100 nm space adjacent to the sarcolemma.
Because the localization and intensity of fluo-4 fluorescent
areas detected in TIRF mode showed high variability
within and between cells, we measured the average increase
of fluo-4 fluorescence over the entire cell footprint (Fig. 2B
and C). We believe that the increase of fluo-4 fluorescence is
indicative of ECCE, since the pharmacological profile of the
Ca2+ response closely matches that ascribed to ECCE (19);
in particular: (i) it was dependent on the presence of extra-
cellular Ca2+ and did not occur in cells perfused with KCl
plus 100 mM La3+, a non-specific blocker of plasma mem-
brane Ca2+ channels; (ii) it was blocked by pre-treatment
of cells with 10 mM nifedipine and by 10 mM SKF-96365,
a selective inhibitor of receptor-mediated Ca2+ entry and
voltage-gated Ca2+ entry (31,32) (Fig. 2B and C). These
results support the use of TIRF microscopy to directly
measure changes in [Ca2+] occurring within a domain very
close to the plasma membrane.
Excitation-coupled calcium entry in myotubes from MHS
and CCD patients
Having established the conditions to detect Ca2+ influx by
TIRF microscopy, we studied ECCE in fluo-4-loaded cells
from MHS and CCD patients and compared the peak change
in Ca2+ with that observed in myotubes from control individ-
uals. Figure 3 shows the cumulative data obtained on ECCE in
myotubes from three control individuals and from myotubes
obtained from the different patients bearing the indicated
RYR1 mutations. We assessed the variability of ECCE in myo-
tubes from controls (Supplementary Material, Fig. S1) and
compared the average value with that from MHS and CCD
myotubes. Under our experimental conditions, the cells from
MHS patients harbouring RYR1 mutations, except for those
harbouring the p.R2336H and p.R614C substitutions, exhib-
ited a significantly higher ECCE (ranging from 1.3–1.5
fold) compared with that observed in control cells. The most
striking result was observed in cells from CCD patients,
which exhibited a 1.5–2.66-fold increase in ECCE compared
with that observed in control cells. To determine whether the
increase in ECCE in MHS and CCD myotubes is linked to
changes in the expression of the DHPR, we examined the
content of the Cav1.1 transcript by real-time PCR. We found
that the levels of expression of Cav1.1 were 1+ 0.4, 0.78+
0.24 and 1.67+ 0.44 in control, MHS and CCD myotubes,
respectively (mean+SD, n ¼ 3). The increase, if any, of
Cav1.1 transcript in CCD was not statistically significant
(P , 0.123), and appears to be too low to account for the
extent of ECCE increase in CCD myotubes.
We reasoned that the larger depolarization-induced Ca2+
influx in cells from CCD patients compared with that measured
in myotubes from both controls and MHS patient may represent
a mechanism underlying not only the increased resting [Ca2+],
but also the physiological activation of membrane-bound Ca2+-
dependent enzymes. A previous study on a knock-in animal
model carrying the Y522S MHS-associated substitution
showed that myotubes from the knock-in but not from control
mouse display higher reactive nitrogen species (RNS) gener-
ation, most likely due to the activation of NOS (33). On the
basis of these observations on the mouse model, we examined
whether alterations of ECCE might affect RNS generation via
Figure 1. Cytoplasmic Ca2+ homeostasis in myotubes from controls, MHS and CCD patients. (A) Average resting myoplasmic [Ca2+] (fura-2 fluorescence ratio)
of human myotubes from three healthy controls and from the indicated MHS and CCD patients. Measurements (mean+SEM) were made on cells perfused in
Krebs–Ringer containing 2 mM Ca2+. (B) Mean (+SEM) peak global [Ca2+] increase of myotubes to 100 mM KCl Krebs–Ringer containing 100 mM La3+.
Statistical analysis was performed using the ANOVA test followed by Dunnett’s post hoc test. ∗P , 0.0004, ∗∗P , 0.0001, ∗∗∗P, 0.0015 compared with
cells from control individuals.
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the activation of NOS associated with the surface membrane of
human skeletal muscle cells.
RNS generation
The detection of NOS/RNS on the plasma membrane of
human myotubes was carried out by immunohistochemistry
in the TIRF mode. As can be seen in Figure 4A, NOS is dis-
tributed in distinct fluorescent dots or puncta, which are pre-
sumably localized on the surface membrane of the human
myotube. The cells were also stained with anti-RyR1 Abs
and monitored by epifluorescence (Fig. 4A). We next investi-
gated whether ECCE activates the generation of RNS, by fol-
lowing the changes in the fluorescence of diacetate
(4-amino-5-methylamino-2,7-difluorofluorescein) (DAF-FM)
by TIRF microscopy. Previous studies have indicated high
background fluorescence and relatively low signal-to-noise
ratio when using conventional epifluorescence microscopy in
combination with DAF-FM (34). Using the same protocol uti-
lized to stimulate ECCE, we show that RNS generation occurs
in myotubes stimulated with KCl and that TIRF microscopy is
suited to measure such localized events. Figure 4B shows
time-lapse changes of DAF-FM fluorescence before the appli-
cation of 100 mM KCl (t ¼ 0) and 2, 5, 10 and 15 s after its
application. The increase of DAF-FM fluorescence occurs on
discrete areas of the surface membrane and since the localiz-
ation and intensity of the DAF-FM signal exhibit remarkable
variation within each cell, we measured the increase of the flu-
orescent signal over the entire footprint of cell (see Sup-
plementary Material, Fig. S2, for a higher resolution image
of the increase in DAF-FM fluorescence at 5 s after stimu-
lation). As shown in Figure 4C, DAF-FM fluorescence
shows a peak at 5 s after the addition of KCl and then
decays rapidly to pre-stimulation levels. This increase in fluor-
escence could be prevented by pre-incubating myotubes with
50 mM of the NOS inhibitor L-NNA (35) during the loading
Figure 2. TIRF measurements of Ca2+ influx induced by KCl in human myotubes. (A) Myotubes from a control patient were visualized by brightfield (top left
panel), with an SRIC filter to visualize and fix the focal plane of the coverglass/cell membrane interphase (top central panel) and by exciting fluo-4 with a Sap-
phire laser (488 excitation, top right panel) and by monitoring membrane fluorescence. The bottom panels show pseudo-coloured ratiometric images (peak flu-
orescence after addition of KCl/resting fluorescence) of fluo-4 fluorescence changes at the indicated time-points after application of KCl. Cells which had been
pre-treated with 500 mM ryanodine during fluo-4 loading were individually stimulated with 100 mM KCl and the changes in fluorescence were monitored as
detailed in Materials and Methods. Bar indicates 30 mm. Images were acquired through a 60× TIRF objective and analysed using Metamorph. (B) Mean
(+SEM) peak increase of fluo-4 fluorescence induced by 100 mM KCl in the presence of 100 mM La3+, 10 mM nifedipine and 10 mM SKF-96365. Statistical
analysis was performed using the ANOVA test followed by Dunnett’s post hoc test. ∗P, 0.0001 compared with untreated cells. (C) Representative traces
showing changes in membrane-associated [Ca2+] of individual cells (F: fluorescent value at any time point; F0: fluorescent value at t ¼ 0) to KCl alone (a),
KCl plus 10 mM nifedipine (b), 100 mM La3+ (c) and 10 mM SKF-96365 (d).
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procedure and throughout the experiment. Furthermore, omis-
sion of Ca2+ from the KCl solution also resulted in negligible
RNS generation (Fig. 4D), indicating that this event depends
on the influx of Ca2+ from the extracellular environment.
We next measured ECCE-dependent RNS formation in
myotubes from three control individuals and in cells from
MHS and CCD patients. Figure 5 summarizes the peak
changes in DAF-FM fluorescence (△F) in cells stimulated
with 100 mM KCl. As shown, control cells produce negligible
amounts of RNS, and the increases in fluorescence in the pres-
ence or absence of 50 mM L-NNA were not significantly
different. On the other hand, myotubes from all MH and
CCD patients (except for CCD myotubes bearing the
R4861H mutation, where the variability was greater and did
not reach statistical significance) produced significantly
larger amounts of RNS during ECCE, compared with controls.
Figure 5 also shows that the increase in DAF-FM fluorescence
was largely prevented by L-NNA, indicating that it is due to
the activation of NOS. Altogether, these results indicate a
link between ECCE and RNS and show that myotubes from
patients carrying RYR1 mutations produce more NO radicals
than cells from control individuals. The activation of NOS
has been linked to the activation of gene transcription via
nuclear translocation of calcium-dependent transcriptional
factor(s) (36). In the next set of experiments, we examined
the influence of ECCE on nuclear translocation of NFAT.
ECCE affects NFTAc1 nuclear translocation in muscle
cells from CCD patients
NFTAc1 nuclear translocation is known to be an important
step of the slow fibre-type differentiation programme
(23,24). We focused on this isoform of NFAT since it was
Figure 3. ECCE in human myotubes from control, MH and CCD patients.
Experiments were performed in TIRF mode as outlined in Figure 2. Bar histo-
grams show mean (+SEM) peak Ca2+ increase induced by 100 mM KCl. Data
from control myotubes are the mean (+SEM) change in fluorescence
measured in myotubes obtained from three control individuals. Statistical
analysis was performed using the ANOVA test followed by Dunnett’s post
hoc test. ∗P , 0.002, ∗∗P , 0.0001, ∗∗∗P, 0.007 and ∗∗∗∗P , 0.05 com-
pared with cells from control individuals.
Figure 4. Depolarization-induced Ca2+ influx activates NOS. (A) Photomi-
cropgraphs showing a human myotube stained for RyR and NOS. Left
panel, brightfield; central left, epifluorescence showing anti-RyR1 staining;
central right, SRIC filter; right, TIRF image of the same myotube showing dis-
creet punctuated fluorescence on plasma membrane with anti-NOS. Images
were acquired through a 100× TIRF objective (1.45 NA). Bar indicates
20 mm. (B) Myotubes were loaded with the RNS-sensitive dye DAF-FM
and visualized by brightfield (a), with an SRIC filter (b) and at the indicated
time points after the addition of KCl. Images were acquired through a 60×
TIRF objective (1.49 NA). Panels show pseudo-coloured (Metamorph) micro-
graphs of ratiometric changes (F/F0) of DAF-FM fluorescence. Bar indicates
30 mm. (C) Representative traces showing changes in membrane-associated
DAF-FM fluorescence in a cell from an MHS individual (F: fluorescent
value at any time point; F0: fluorescent value at t ¼ 0) after the addition of
100 mM KCl in an untreated cell (continuous trace) and in a cell pre-treated
with 50 mM of the NOS inhibitor L-NNA. (D) Mean (+SEM) peak increase
in DAF-FM fluorescence induced by 100 mM KCl in the presence (n ¼ 23
cells analysed) or absence (n ¼ 15 cells analysed) of extracellular Ca2+. Stat-
istical analysis was performed using Student’s t-test; ∗P , 0.001.
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recently demonstrated that NFATc1 can be induced to translo-
cate from the cytoplasm to the nucleus by treating myotubes
with KCl and that sustained nuclear retention was promoted
by external Ca2+ (37,38).
Figure 6A shows the subcellular distribution of NFATc1 in
myotubes from control and CCD patients after treatment with
60 mM KCl. KCl-induced depolarization of ryanodine-treated
cells is deemed to increase Ca2+ influx into myotubes (as
shown in Figs 2 and 3), an event which affects the subcellular
distribution of NFATc1. As expected, stimulation of Ca2+
influx is accompanied by an increase of the nuclear distri-
bution of NFATc1. The nuclear/cytoplasm fluorescence ratio
of NFATc1 was significantly higher and remained elevated
after 5 and 30 min of KCl stimulation, in myotubes from the
CCD patients (Fig. 6B, left panel), a result consistent with
the larger extent of ECCE in these myotubes compared with
that of cells from controls. It should also be pointed out that
the NFAT nuclear-to-cytoplasmic ratio was already slightly
but significantly elevated in unstimulated myotubes from
CCD patients. When KCl plus 100 mM La3+ was added to
cells from CCD patients, the nucleus/cytoplasmic fluorescent
ratio was significantly reduced; similarly, pre-treatment of
myotubes from CCD patients with L-NNA significantly
reduced the nuclear translocation of NFATc1 (Fig. 6B, right
panel). Finally, addition of 600 mM 4-chloro-m-cresol, a
direct pharmacological RyR1 activator, had a negligible
effect on NFAT translocation in CCD myotubes (Fig. 6B,
right panel), indicating that depolarization of CCD myotubes
causes NFAT translocation mainly by activating influx of
Ca2+.
These results suggest that some genes under the control of
the transcriptional factor NFATc1 might be up-regulated in
muscles from CCD individuals. Among many such genes,
we focused on that encoding IL-6 since previous reports
have demonstrated a link between Ca2+, RYR1 mutations
and IL-6 release (8). We next studied the effect of
KCl-induced depolarization on IL-6 release from myotubes
from controls and CCD patients. In the presence of 2 mM
Ca2+, treatment of myotubes from control individuals with
60 mM KCl resulted in a significant release of IL-6, which
was blocked when the experiment was performed in the pres-
ence of 100 mM La3+ (Fig. 6C), supporting the hypothesis that
Figure 5. ECCE-induced RNS generation is increased in myotubes from MHS and CCD patients. Experiments were performed in TIRF mode as outlined in
Figure 4. Bar histograms show mean (+SEM) peak DAF-FM fluorescent increase induced by 100 mM KCl in untreated cells (white bars) and in cells pre-
incubated for 30 min with 50 mM NOS inhibitor L-NNA. Statistical analysis was performed using the ANOVA test followed by Dunnett’s post hoc test.
∗P , 0.015, ∗∗P , 0.0001, ∗∗∗P , 0.0003 with respect to untreated cells from controls.
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Ca2+ influx plays a role in KCl-induced IL-6 release from
myotubes. Myotubes obtained from CCD patients released
IL-6 to a much higher extent compared with control cells
(note that the IL-6 scale bars are different between controls
and CCD patients) (Fig. 6C, right panel). IL-6 is released
from CCD myotubes in the absence of KCl, and the addition
of 60 mM KCl + 2 mM Ca2+ results in a further release of
IL-6. The latter event was partially reversed when the exper-
iment was performed in the absence of added Ca2+ and in
the presence of 100 mM La3+. These results suggest that
depolarization-induced IL-6 release from human myotubes is
mediated, at least in part, by the influx of extracellular Ca2+.
DISCUSSION
In the present study, we show that cultured myotubes from
patients with MH and CCD have an altered ECCE. In particu-
lar, ECCE is enhanced to a much greater extent in cells from
patients with CCD compared with those with MH and control
individuals. We also show that the Ca2+ influx via ECCE has
at least two physiological effects: it induces (i) generation of
RNS via the activation of NOS expressed in myotubes, and
(ii) nuclear translocation of the Ca2+-sensitive transcription
factor NFAT. The dysregulation of Ca2+ homeostasis seen
in myotubes from CCD patients (increase of the resting
[Ca2+] and increased Ca2+-influx) leads to downstream
effects such as to the nuclear translocation of the transcription
factor NFAT and to higher levels of IL-6 release.
Analysis of calcium influx of human myotubes from MH
and CCD patients by TIRF microscopy
A great deal of data (8,13,21,32,39) have shown that a number
RYR1 mutations cause the expression of leaky channels in
myotubes from MH and CCD patients and this is associated
with an elevation of the resting [Ca2+]. This increased Ca2+
leak via mutant RYR1s might also be associated with
defect(s) in the regulation of the plasma membrane Ca2+
influx pathways, whereby the long-term Ca2+ store-refilling
process is affected. In this study, we monitored for the first
time calcium influx in myotubes expressing naturally occur-
ring RYR1 mutants from CCD and MH patients, by exploiting
TIRF microscopy, the state-of-the-art technology to monitor
fluorescent signals with a high signal-to-noise ratio from a
100 nm thick optical section localized on or very close to
the plasma membrane. Cherednichenko et al. (18) suggested
Figure 6. ECCE induces NFAT nuclear translocation and enhances IL-6 release by myotubes from CCD patients. (A) Myotubes from a control and CCD indi-
viduals were pre-treated with 500 mM ryanodine and incubated in Krebs–Ringer solution or with 60 mM KCl for 5 min at 378C. Cells were immediately fixed
with ice-cold methanol:acetone (1:1) and processed for immunofluorescence as described in Materials and Methods. Images (60× TIRF objective) show epi-
fluorescence using anti-NFATc1 Ab (green) and DAPI (blue) for nuclear staining. Bar: 30 mm. (B) Left panel: bar histograms showing the nuclear-to-cytoplasm
NFAT fluorescence intensity in cells from three different control individuals (n ranged between 25 and 35 individual cells) and two different CCD individuals
(n ranged between 35 and 38 individual cells) in untreated cells (white bars) and cells treated for 5 min (light grey) and 30 min (dark grey) with 60 mM KCl plus
2 mM Ca2+. Right panel: bar histograms showing the nuclear-to-cytoplasm NFAT fluorescence intensity in cells from two different CCD individuals in (i) cells
pre-treated with ryanodine, and stimulated 5 min with KCl in the presence of 2 mM Ca2+, 100 mM La3+, or pre-treated with 50 mM L-NNA + 2 mM Ca2+, or (ii)
in non-ryanodine pre-treated cells, stimulated for 5 min with 600 mM 4-chloro-m-cresol in the presence of 2 mM Ca2+ or 100 mM La3+ (n ranged between 19 and
70 individual cells). The area over the nucleus was selected by using the DAPI image and transferred to the NFAT fluorescence image using the ‘transfer region
option’ of the Metamorph software package. Average fluorescent intensity in nuclei and region excluding nuclei was calculated with Metamorph. Only myotubes
containing more than two nuclei were included and the average fluorescent intensity of all the nuclei of one cell was averaged per cell. ∗∗P, 0.03, ∗P , 0.0001
compared with controls. (C) IL-6 release induced by 60 mM KCl from myotubes from two control individuals (scale bar from 0 to 2000 pg/106 cells) and in
myotubes from two CCD patients (scale bar from 0 to 10 000 pg/106 cells). After 30 min of incubation with 60 mM KCl, the medium was replaced by differ-
entiation medium and cells were incubated at 378C for four additional hours. The amount of IL-6 released was quantified as described in Materials and Methods.
Bar histograms show the mean (+SEM) of 7–15 measurements. Statistical analysis was performed using the ANOVA followed by Dunnett’s post hoc test.
∗∗P, 0.02 and ∗P , 0.0007.
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that muscle cell depolarization not only triggers Ca2+ release,
but also calcium entry via ECCE and that the latter event
requires the interaction of the DHPR with the RyR. These
results imply that the molecular physiology of ECCE might
be affected by mutations in the DHPR and/or RyR1. The
results reported here support and extend this idea. We found
that the expression of RYR1 mutations linked to both MH
and CCD induced an increase of ECCE which is most likely
not due to changes in the expression level of the Cav1.1 tran-
script. In particular, we found that the enhancement of ECCE
appears to be correlated with the effect of the RyR mutant on
the resting calcium concentration. The myotubes expressing
leaky RyR mutants which are associated with a significantly
higher resting [Ca2+] also had a significantly larger ECCE
(compare Figs 1A and 3). These results are consistent with
the idea that variations of the resting [Ca2+] cannot be
ascribed to a change in calcium fluxes across SR(ER) mem-
branes only, unless they also cause changes of calcium
fluxes at the level of the plasma membrane (17). Myotubes
from MHS/CCD patients may adapt to the presence of
mutations in the RYR1 by increasing Ca2+ influx across the
sarcolemma. The increased ECCE may be a compensatory
mechanism particularly relevant in CCD patients to cope
with the low levels of Ca2+ released from the SR during
T-tubule depolarization.
NOS activation by ECCE
The enhancement of ECCE, which is particularly relevant in
CCD patients, may affect the activity of membrane-bound
enzymes allosterically regulated by calcium. In this context, it
is worth mentioning that eNOS and nNOS, the two nitric oxide
synthase isoforms, are constitutively expressed in skeletal
muscles (25), are Ca2+-sensitive and are activated by skeletal
muscle contraction. Depletion of intracellular Ca2+ stores has
been shown to activate NOS in a number of cell types (40,41).
We hypothesized that one of the functions of ECCE may be to
activate the Ca2+-sensitive NOS in myotubes, leading to the gen-
eration of the second messenger and free radical NO. Indeed,
Durham et al. (33) recently suggested that in the MHS RYR1
knock in Y522S mouse model, generation of RNS is linked to
Ca2+ leak from the SR, and this leads to heat stroke and
sudden death. By exploiting the RNS indicator DAF-FM and
the same protocol used to measure ECCE, we demonstrate that
ECCE leads to the generation of RNS. We are confident that
the DAF-FM signal is due to Ca2+-dependent NOS activation
since it was inhibited by the NOS inhibitor L-NNA (35) and by
preventing calcium entry with extracellular Ca2+ chelators.
Although measurements of RNS production by DAF-FM dye
in epifluorescence mode have shown an irreversible increase of
the fluorescent signal, in our experimental setting we found
that the DAF-FM fluorescent signal is reversible. A number of
reasons may account for the decay of the DAF-FM signal. As
reported previously by Sheng et al. (42), when measuring NO
synthesis in vascular endothelial cells, the dye may bleach
during excitation, especially with the powerful Sapphire laser
we used in the present experiments. The second possibility is
also linked to our experimental set up. We think that the decay
of DAF-FM signal is indicative of the diffusion of the dye
away from the TIRF focal plane. Contrary to our expectations
however, the overall peak DAF-FM fluorescent increase was
larger in cells from MHS individuals compared with that
observed in cells from CCD patients, even though the latter
showed significantly higher ECCE. An investigation on the
Ca2+ dependence of NOS activation (43) showed that at a pH
of 7.1, formation of NO by NOS has a bell-shaped curve, with
maximal activity between 1 and 100 mM and thereafter the
activity is drastically reduced. Furthermore, the activity of
NOS increases greatly with variations in [Ca2+] over the physio-
logical range, i.e. between 100 and 200 nM (43). Additionally,
Schmidt et al. (44) showed that long-lasting increases in Ca2+
down-regulate NO formation. Thus, the enhanced Ca2+ influx
triggered in myotubes derived from CCD patients may affect
the enzymatic activity of NOS, leading to lower amounts of
NO formation as observed in cells from CCD patients compared
with those from MHS individuals.
NFAT gene expression and ECCE
As to the subcellular distribution of the Ca2+-sensitive tran-
scription factor NFAT, our results are in agreement with pre-
vious reports showing that in cultured myotubes the c1
isoform of NFAT translocates to the nuclei in a Ca2+-
dependent manner and that K+-induced depolarization and
electrical stimulation induce nuclear translocation of
NFATc1 and that extracelluar Ca2+ contributes to the acti-
vation of NFAT (37,38,45). In fact, we found that
ECCE-induced nuclear translocation of NFAT was more pro-
nounced in myotubes from the CCD patients compared with
myotubes from controls. Interestingly, nuclear distribution of
NFATc1 in adult skeletal muscle fibres appears to be an
important step of the slow fibre-type differentiation pro-
gramme (24,46) and this is consistent with the fibre type-1 pre-
dominance observed in CCD patients. The present report
indicates that stimulation of NOS is involved in the NFAT-
dependent transcription activity in human myotubes, a con-
clusion in agreement with data provided by Drenning et al.
(36), who showed that NO enhances Ca2+-dependent nuclear
accumulation and transcriptional activity of NFAT in mouse
muscle cells. We have previously demonstrated that the
release of IL-6 from cultured human myotubes is Ca2+ depen-
dent and is inhibited by cyclosporine, a blocker of the NFAT
pathway (8). The involvement of NFAT in the activation of
IL-6 is consistent with (i) the presence of NFAT-responsive
elements in the promoter of the human IL-6 gene (47), and
with (ii) the inhibition of IL-6 production in vascular human
smooth muscle cells by a specific NFAT blocker (48). In the
present report, we confirm and extend these observations
and show that IL-6 release from human myotubes in vitro is
mediated by two components: one is dependent on the elev-
ated resting [Ca2+] and the other is dependent on the influx
of extracellular calcium induced by prolonged membrane
depolarization.
In conclusion, we believe RyR mutations causing alterations
of Ca2+ homeostasis via leaky RyR channels and/or enhanced
ECCE also lead to an up-regulation of ‘NFAT-dependent path-
ways’ resulting in an increased release of the
pro-inflammatory cytokine IL-6. Future studies aimed at
understanding the roles of IL-6 in muscle cell physiology
and the implications of its enhanced release from cells from
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patients with CCD and other neuromuscular disorders may
help shed light into some of the pathological alterations seen
in patients with ryanodinopathies such as muscle cramping
and muscle protein breakdown (49,50).
MATERIALS AND METHODS
Materials
Dulbecco’s modified Eagle’s medium (DMEM) containing
4.5 mg/ml of glucose, penicillin G, streptomycin, Fluo-4/AM
and DAF-FM, AlexaFluor 488-conjugated chicken anti-rabbit
IgG, AlexaFluor 568-conjugated donkey anti-mouse IgG and
4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) were
from Life Technologies, Ltd. Insulin was purchased from Eli
Lilly and Company, Indianapolis, IN, USA. Cell culture
plastic ware was from Becton Dickinson. Glutamine, HEPES,
BSA, EGF, SKF-96365 creatine anti-a-actinin Abs were from
Sigma Chemical. Fura-2/AM, nifedipine and ryanodine were
from Calbiochem. Rabbit anti-NFATc1 (sc-13033), goat
anti-NOS (sc-49058) and FITC-conjugated donkey anti-goat
IgG were from Santa Cruz Biotechnology. Mouse anti-RyR
Abs were from Affinity Bioreagents. IL-6 was determined by
ELISA using the PeliPair reagent kit Sanquin reagents (The
Netherlands). Qualitative determination of CRP was performed
using the Humatex kit (HUMAN Gesellschaft fu¨r Biochemica
und Diagnostica mbH, Wiesbaden, Germany). All other chemi-
cals were reagents of highest available grade.
Human muscle cells
Primary muscle cell cultures were established from fragments
of muscles obtained from biopsies of patients undergoing
diagnostic testing for MH (4 MHS), from patients diagnosed
as CCD from Genethon (Institut de Myologie, Paris, France)
and CHUV (Lausanne, Switzerland), as described previously
(8). Mutation screening confirmed the presence of the follow-
ing RYR1 mutations which have been associated with the MHS
phenotype: c.7007G . A (p.R2336H) (51), c.6502G . A
(p.V2168M) (8,11), c.1840C . T (p.R614C) (11) and
c.8189A . G (p.D2730G) (51). One CCD patient was hetero-
zygous for the newly identified substitutions c.130C . T and
c.2366G . T (p.R44C + p.R789L), whereas the other was
heterozygous for the CCD-linked (10,11,16) c.14582G . A
mutation (p.R4861H). Molecular genetic analysis performed
by sequencing genomic DNA from the other two CCD patients
failed to identify any RYR1 substitution though, based on their
neurological and histological examinations, they were clini-
cally classified as CCD patients. Cells were cultured on
0.17 mm thick glass coverslips in growth medium and
induced to differentiate into myotubes by culturing them in
differentiation medium (DMEM plus 4.5 mg/ml glucose,
0.5% BSA, 10 ng/ml EGF, 0.15 mg/ml creatine, 5 ng/ml
insulin, 200 mM glutamine, 600 ng/ml penicillin G and strepto-
mycin, and 7 mM HEPES, pH 7.4) for 7–10 days.
Calcium measurements
Myotubes were loaded with fura-2 or fluo-4 (final concen-
tration 5 mM) in differentiation medium for 30 min at 378C,
after which the coverslips were mounted onto a 378C thermo-
statically controlled chamber which was continuously per-
fused with Krebs–Ringer medium; individual cells were
stimulated by means of a 12- or 8-way 100 mm diameter
quartz micromanifold computer-controlled microperfuser
(ALA Scientific Instruments, Westbury, NY, USA), as
described previously (8). (i) For global changes in the intra-
cellular Ca2+ concentration, the fluorescent ratiometric Ca2+
indicator fura-2 was used. Online measurements were
recorded using a fluorescent Axiovert S100 TV inverted
microscope (Carl Zeiss GmbH, Jena, Germany) equipped
with a 20× water-immersion FLUAR objective (0.17 NA)
and filters (BP 340/380, FT 425, BP 500/530) and attached
to a Hamamatsu multiformat CCD camera. Changes in fluor-
escence were analysed using an Openlab imaging system
and the average pixel value for each cell was measured at exci-
tation wavelengths of 340 and 380 nm as described previously
(8). (ii) The dynamics of [Ca2+] influx were investigated by
TIRF microscopy using the fast Ca2+ indicator Fluo-4 as
described previously (52). Glass coverslip grown and differen-
tiated human myotubes were mounted on a thermostated per-
fusion chamber, bathed continuously in Krebs–Ringer. ECCE
was measured after the application of 100 mM KCl to myo-
tubes pre-treated with 500 mM ryanodine to block RyR1-
mediated Ca2+ release. Online fluorescence images were
acquired using an inverted Nikon TE2000 TIRF microscope
equipped with an oil immersion CFI Plan Apochromat 60×
TIRF objective (1.49 NA) and an electron multiplier Hama-
matsu CCD camera C9100–13 which allows fast data acqui-
sition. Our TIRF microscope is equipped with an SRIC cube
in order to maintain the focal plane at the coverglass/cell
membrane contact prior to and during TIRF acquisition. The
focus was maintained at the coverglass/cell membrane
contact by using the PFS that exploits an infrared laser beam
and a quadrant diode for the online control of the microscope’s
focusing motor. Fluo-4 loaded cells were excited with a solid-
state laser beam at 488 nm and the emitted fluorescence was
collected through a 520 narrow-band filter. Data were ana-
lysed using Metamorph imaging software (Molecular
Devices).
Real-time PCR
At the end of the Ca2+ measurement experiments, myotubes
from controls, MH and CCD patients were scraped off the
glass coverslips, pelleted and stored in liquid nitrogen. Total
RNA was extracted (Qiagen, Basel, Switzerland) and treated
with deoxyribonuclease I (Invitrogen, Carlsbad, CA, USA).
After reverse transcription using 500 ng of RNA (high-
capacity cDNA reverse transcription kit, Applied Biosystems,
Forster City, CA, USA), cDNA was amplified by quantitative
real-time PCR using SYBR Green technology (Fast SYBR
Green Master Mix, Applied Biosystem) as described
previously (52) and the following primers: b-actin
(forward 5′-CATGTACGTTGCTATCCAGGC-3′ and reverse
5′-CTCCTTAATGTCACGCACGAT-3′), desmin (forward
5′-AACCAGGAGTTTCTGACCACG-3′ and reverse 5′-TTG
AGCCGGTTCACTTCGG-3′), Cav1.1 (forward 5′-ATGAC
GACCTACGGAGCCTT-3′ and reverse 5′-ACGAACATGC
ACCTAGCCAC-3′). Gene expression was verified using
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b-actin as a housekeeping gene and normalized for the early
myotube differentiation marker desmin as reference for myo-
tubes content. Cav1.1 gene expression in MH and CCD myo-
tubes was calculated as a fold increase compared with that
observed in myotubes from control individuals.
Reactive nitrogen species
The generation of RNS was followed by monitoring the
increase in fluorescence of the dye DAF-FM at 378C
(34,40). Briefly, coverslip grown and differentiated myotubes
were loaded with 10 mM DAF-FM for 30 min at 378C in differ-
entiation medium in the presence of 500 mM ryanodine. Cover-
slips were transferred onto the stage of a Nikon Eclipse
TE2000-E fluorescent microscope; the cells were excited at
488 nm and the emission was followed at 510 nm as described
above for fluo-4 measurements.
Immunofluorescence
Indirect immunofluorescence was performed on methanol:ace-
tone (1:1)-fixed myotubes using rabbit anti-NFATc1 (final
concentration 10 mg/ml), goat anti-NOS, mouse anti-RyR, fol-
lowed by the appropriate fluorescently labelled secondary anti-
bodies. Nuclei were visualized by counterstaining with DAPI
(100 mM) prior to mounting the coverslips. For experiments
monitoring NFAT localization, cells were either unstimulated,
incubated with 500 mM ryanodine and stimulated with 60 mM
KCl as indicated or stimulated with 600 mM 4-chloro-m-cresol
without ryanodine pre-treatment. Cells were then fixed as
described above and NFAT localization was monitored by epi-
fluorescence through an oil immersion CFI Plan Apochromat
60× TIRF objective (1.49 NA) using appropriate filters for
FITC and DAPI detection and processed as described below
using the Metamorph (Molecular Devices) 5.7.4 software
package. First, the area around the nucleus was selected as a
‘region of interest’ using the DAPI image and transferred to
the NFAT fluorescence image using the ‘transfer region’
option. The average fluorescent intensity in nuclei and
region excluding nuclei was averaged and the ratio of the
intensity in the nucleus to cytoplasm was calculated. Only
myotubes containing more than two nuclei were included.
For NOS, surface fluorescence was monitored by means of
an oil immersion CFI Plan Apochromat 100× TIRF objective;
the focal plane at the coverglass/cell membrane contact was
first visualized with the SRIC cube and this focal plane was
maintained with the PFS.
IL-6 release from myotubes
IL-6 release from human myotubes (two control individuals
and two CCD patients) was performed as described previously
(8) except that cells were stimulated with 60 mM KCl in the
presence of 2 mM Ca2+ or in the presence of 100 mM La3+
or incubated with Krebs–Ringer (+2 mM Ca2+) at 378C.
After 30 min, the medium containing 60 mM KCl was replaced
by differentiation medium and the cells were incubated at
378C for an additional 4 h. The culture medium was then har-
vested, centrifuged to remove any cell debris or cells which
may have detached during the incubation, and the supernatant
(200 ml) was assayed for IL-6 by ELISA using the PeliPair
reagent kit following the manufacturer’s recommendations.
Statistical analysis
Statistical analysis was performed using Student’s t-test for
two populations. When more than two samples were com-
pared, analysis was performed by the ANOVA test followed
by Dunnett’s post hoc test, which is specifically designed for
situations where all groups are to be compared against one
‘reference’ group. The PROC MIXED statistical analysis
program (SAS 9.2) was used for statistical analysis. Values
were considered significant when P, 0.05.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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